Releases
ATRS
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest Antares Pharma Inc (ATRS) stock and general news. This information may help you make smarter investment decisions.
About ATRS
Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products and technologies. The Company develops, manufactures, and commercialize, for itself or with partners, therapeutic products using its drug delivery systems. The Company products include XYOSTED, NOCDURNA, Epinephrine Injection USP, Sumatriptan Injection USP, Makena and Teriparatide Injection. Its XYOSTED injection product for subcutaneous administration of testosterone replacement therapy (TRT) in adult males for conditions associated with a deficiency or absence of endogenous testosterone. NOCDURNA is used for the treatment of nocturia due to nocturnal polyuria (NP) in adults who awaken at least two times per night to urinate. Its Epinephrine Injection USP products is indicated for emergency treatment of severe allergic reactions including those that are life threatening (anaphylaxis) in adults and certain pediatric patients.